Misbah Tahir - Nov 27, 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Financial Officer
Signature
/s/ Misbah Tahir
Stock symbol
IGMS
Transactions as of
Nov 27, 2023
Transactions value $
-$4,024
Form type
4
Date filed
11/29/2023, 08:49 PM
Previous filing
May 25, 2023
Next filing
Mar 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $2.74K +234 +0.46% $11.71 50.9K Nov 15, 2023 Direct F1
transaction IGMS Common Stock Sale -$6.76K -1.34K -2.62% $5.06 49.6K Nov 27, 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F3 This transaction was executed in multiple trades at prices ranging from $4.96 to $5.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.